{
    "organizations": [],
    "uuid": "8b51d79a1dbd782301fad6e2a83909c6790b226d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-luye-pharma-group-says-cfda-accept/brief-luye-pharma-group-says-cfda-accepted-clinical-trial-application-for-cos-anti-tumor-drug-idUSFWN1QG0J2",
    "ord_in_thread": 0,
    "title": "BRIEF-Luye Pharma Group Says ‍CFDA Accepted Clinical Trial Application For Co's Anti-Tumor Drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Luye Pharma Group Ltd:\n* ‍CFDA OFFICIALLY ACCEPTED CLINICAL TRIAL APPLICATION FOR ANTI-TUMOR DRUG Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-26T17:52:00.000+02:00",
    "crawled": "2018-02-27T14:54:31.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "luye",
        "pharma",
        "group",
        "ltd",
        "officially",
        "accepted",
        "clinical",
        "trial",
        "application",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}